Trials / Unknown
UnknownNCT03414580
Analysis of Volatile Organic Compounds in the Exhaled Air in Inflammatory Bowel Disease
Analysis of Volatile Organic Compounds in Exhaled Air in Patients With Inflammatory Bowel Disease Patients and Healthy Control
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (estimated)
- Sponsor
- Keimyung University Dongsan Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
The availability of noninvasive biomarkers for diagnosis and stratification of inflammatory bowel disease (IBD) courses is lacking. Thus, the aim of this study is to evaluated the accuracy of exhaled breath volatile metabolite analysis on diagnosis and stratification of patients with inflammatory bowel disease.
Detailed description
Background: The diagnosis and differentiation of inflammatory bowel diseases (IBD) is challenging due to the absence of a gold standard diagnostic modality for confirmation. Exhaled breath volatile metabolite analysis focusing on diagnosis and differentiation of IBD is a promising approach. Thus, the aim of this study is to evaluated the accuracy of exhaled breath volatile metabolite analysis for patients with inflammatory bowel disease. Method: A single center, prospective study of diagnostic testing will be conducted, recruiting crohn's disease (CD), ulcerative colitis (UC), and healthy controls (HC). The exhaled breath volatile metabolite will be analyzed using gas chromatography/mass spectrometry (GC-MS). The informations of patient's disease location, disease activity, laboratory parameters and current medications will be collected to determine the feasibility of exhaled breath volatile metabolite analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Breath sampling for volatile organic compounds | Acquisition of exhaled breath sample in exhaled air to be analysed by gas chromatography-mass spectrometry |
Timeline
- Start date
- 2018-02-20
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2018-01-30
- Last updated
- 2020-09-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03414580. Inclusion in this directory is not an endorsement.